Related Experiment Videos
Gi2-mediated activation of the MAP kinase cascade
A M Pace1, M Faure, H R Bourne
1Department of Cellular and Molecular Pharmacology, University of California, San Francisco 94143, USA.
Molecular Biology of the Cell
|December 1, 1995
Summary
The study reveals how Gi2 G protein activates the MAPK pathway, crucial for cell proliferation. This signaling involves beta gamma subunit release and phosphatidylinositol-3 kinase activation, offering insights into cancer mechanisms.
Area of Science:
- Cellular signaling pathways
- G protein-coupled receptors
- Oncogenesis
Background:
- Heterotrimeric G proteins of the Gi class transmit signals from receptors.
- The alpha subunit of Gi2 (alpha i2) is oncogenic when constitutively active (gip2).
- Gi2's role in cellular proliferation is linked to the MAPK signaling cascade.
Purpose of the Study:
- Investigate the mechanism of Gi2 activation of the MAPK cascade.
- Utilize a pertussis toxin (PTX)-resistant alpha i2 mutant to specifically study Gi2 signaling.
- Determine the role of Ras and Gi2 subunits in MAPK activation.
Main Methods:
- Transient expression of PTX-resistant alpha i2 in Chinese hamster ovary (CHO) cells.
- PTX treatment to isolate Gi2 signaling.
- Analysis of MAPK and MEK activation.
- Expression of dominant-negative Ras to block signaling.
- Assessment of Ras GTP-bound levels.
- Investigation of beta gamma subunit and phosphatidylinositol-3 kinase involvement.
Main Results:
- Receptor-mediated activation of PTX-resistant Gi2 led to MAPK and MEK activation.
- Gi2-induced MAPK/MEK activation was blocked by dominant-negative Ras.
- Gi2 activation did not significantly increase GTP-bound Ras.
- Gi2 stimulates the MAPK pathway partly through beta gamma subunit release and phosphatidylinositol-3 kinase activation.
Conclusions:
- Gi2 G protein directly activates the MAPK signaling cascade.
- Ras is involved in Gi2-mediated MAPK activation, but not solely through increased GTP-bound Ras.
- Gi2 signaling to MAPK involves its beta gamma subunit and phosphatidylinositol-3 kinase.